Alcon, líder mundial en el campo de la visión y
división de Novartis, está dando a conocer sus nuevos avances en cirugía de cataratas en
el curso del XXXIII Congreso de la Sociedad Europea de Cataratas y Cirugía Refractiva
(ESCRS), que se celebra en la ciudad de Barcelona entre los días 4 y 9 de septiembre de
2015.
Complementando su extensa gama de lentes intraoculares (LIO), equipos para cirugía
refractiva de cataratas y soluciones farmacéuticas, Alcon ha presentado sus lentes
intraoculares de corrección de la presbicia AcrySof®
IQ PanOptix®
, el Sistema Inyector
Precargado UltraSert™ con LIO Asféricas AcrySof®
IQ, y el sistema de diagnóstico ORA
System®
con tecnología VerifEye+™.
Estas innovaciones, que se han dado a conocer en
el transcurso del ESCRS, seguirán el proceso posterior de comercialización en diferentes
países europeos.
“Alcon está muy satisfecha con la impresionante acogida que estos nuevos productos han
recibido por parte de los cirujanos oftalmólogos.
Nos sentimos muy orgullosos de
desarrollar tecnologías que satisfacen las necesidades de los cirujanos especializados en
cirugía refractiva y de cataratas", señala Franck Leveiler, Director de I+D Quirúrgico de
Alcon. “Como empresa líder en el cuidado de la visión, estamos firmemente decididos a
acelerar la innovación.
Desarrollando mejores lentes intraoculares e instrumentos que
facilitan la visualización, navegación y guiado durante la cirugía de cataratas, mejoramos
los resultados en los pacientes sometidos a este tipo de intervenciones".
2/5
Alcon también ha patrocinado durante el congreso más de 15 sesiones médicas y 24
presentaciones científicas
Diario digital con noticias de actualidad relacionadas con el mundo de la salud. Novedades, encuestas, estudios, informes, entrevistas. Con un sencillo lenguaje dirigido a todo el mundo. Y algunos consejos turísticos para pasarlo bien
Traductor
Showing posts with label Pactience. Show all posts
Showing posts with label Pactience. Show all posts
08 September 2015
30 August 2015
A single cocaine dose lowers perceptions of sadness and anger
A single dose of cocaine can interfere with the ability to recognise negative emotions, according to new research presented at the ECNP conference in Amsterdam.
In a placebo-controlled within subject study, researchers from the Netherlands and Germany took 24 students (aged 19 to 27) with light to moderate cocaine use, and gave them either 300mg of oral cocaine, or a placebo. After 1 to 2 hours,
each participant was then subject to a series of biochemical tests, as well as the facial emotion recognition test to measure response to a series of basic emotions, such as fear, anger, disgust, sadness, and happiness.
They found that in comparison with placebo, a single dose of cocaine caused an increased heart rate, as well as increased levels of the stress hormone cortisol. In addition, the researchers found that the subjects who took cocaine found
it more difficult to recognise negative emotions.
They also found that the subjects who showed a larger cortisol response after taking cocaine had a less marked impairment of negative emotions.
When they were intoxicated with cocaine, their performance was 10% worse compared to their performance during placebo, in recognising sadness and anger’.
As lead researcher, Dr Kim Kuypers (Maastricht University, The Netherlands) said:
‘This is the first study to look at the short-term effect of cocaine on emotions. It shows that a single dose of cocaine interferes with a person’s ability to recognise negative emotions, such as anger and sadness. This might hinder
the ability to interact in social situations, but it may also help explain why cocaine-users report higher levels of sociability when intoxicated – simply because they can’t recognise the negative emotions’.
Commenting for the ECNP, Dr Michael Bloomfield (University College, London) said:
"There are many mental illnesses in which our brains’ ability to recognise the emotions of others are impaired and this new study shows that cocaine may interfere with this process too. Since cocaine changes the level of the brain chemical
dopamine, this new study may have implications for other mental illnesses such as depression and schizophrenia – where dopamine may also be involved in how we recognise emotions. We know that cocaine is a powerful and addictive drug and an important question
remains: does cocaine mess up this process so that when cocaine users are off the drug they feel like other people have more negative emotions?"
Subscribe to:
Posts (Atom)
CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies
Copyright © Noticia de Salud